Abstracts tagged "Integrated Summary of Safety"

Abstract Number: 509 • ACR/ARP Annual Meeting 2019

Safety Profile of Upadacitinib in Rheumatoid Arthritis: Integrated Analysis from the SELECT Phase 3 Clinical Program

Stanley Cohen¹, Ronald van Vollenhoven ², Kevin Winthrop ³, Cristiano A. Zerbini ⁴, Yoshiya Tanaka ⁵, Louis Bessette ⁶, Ying Zhang ⁷, Nasser Khan ⁸, Barbara Hendrickson ⁷, Jose Jeffrey Enejosa ⁷ and Gerd Burmester ⁹, ¹Metroplex Clinical Research Center, Dallas, TX, ²Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands, ³Oregon Health and Science University, Portland, OR, ⁴Centro Paulista de Investigação Clinica, São Paulo, Brazil, ⁵University of Occupational and Environmental Health Japan, Kitakyushu, Japan, ⁶Laval University, Quebec City, QC, Canada, ⁷AbbVie Inc., North Chicago, IL, USA, North Chicago, IL, ⁸Abbvie Inc, North Chicago, IL, ⁹Charité—University Medicine Berlin, Berlin, Germany